Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 5Unknown 2Active not recruiting 1

Sponsor Class

OTHER 9NIH 2OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Breast Neoplasms 104Lymphoma 78Lung Neoplasms 68Colorectal Neoplasms 61Carcinoma, Non-Small-Cell Lung 60Rectal Neoplasms 58Leukemia 56Colonic Neoplasms 56Lymphoma, Follicular 42Precursor Cell Lymphoblastic Leukemia-Lymphoma 39Central Nervous System Neoplasms 39Lymphoma, Large B-Cell, Diffuse 38Prostatic Neoplasms 35Ovarian Neoplasms 33Melanoma 33Lymphoma, Non-Hodgkin 33Head and Neck Neoplasms 32Burkitt Lymphoma 31Leukemia, Lymphocytic, Chronic, B-Cell 30Carcinoma, Ovarian Epithelial 30Lymphoma, Large-Cell, Immunoblastic 28Kidney Neoplasms 28Multiple Myeloma 26Lymphoma, Mantle-Cell 26Lymphoma, B-Cell, Marginal Zone 25Carcinoma, Renal Cell 25Sarcoma 24Neoplasms, Plasma Cell 24Leukemia, Myeloid, Acute 24Hodgkin Disease 23

Interventions

Fluorouracil 2Vincristine 1Paclitaxel 1Leucovorin 1Etoposide 1Epirubicin 1Doxorubicin 1Cyclophosphamide 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × NIH × Neoplasms, Unknown Primary × Clear all
NCT00022178 2013-09-20

Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin

National Cancer Institute (NCI)

Phase 3 Unknown
Tumor-Agnostic

Neoplasms, Unknown Primary

NCT00003558 2013-08-07

Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin

National Cancer Institute (NCI)

Phase 3 Unknown
140 enrolled
Tumor-Agnostic

Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡